Fig. 4From: The expression of interleukin-1β in patients with chronic hepatitis B treated with pegylated-interferon-alpha combined with tenofovir disoproxil fumarate and monotherapyIL-1β expression in Groups B, C, and D. Plasmas were collected from CHB (including 46 patients in Group B, 39 patients in Group C, and 32 patients in Group D). ELISA was used to measure the levels of IL-1β in plasma. The results are presented as the median (IQR). * P < 0.05, **P < 0.01Back to article page